iBio (IBIO) Operating Leases (2021 - 2026)

iBio (IBIO) has 6 years of Operating Leases data on file, last reported at $1.8 million in Q1 2026.

• On a quarterly basis, Operating Leases fell 22.88% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 22.88% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 18.19% from the prior year.
• Operating Leases for Q1 2026 stood at $1.8 million, down from $1.9 million in the prior quarter.
• Over the last five years, Operating Leases for IBIO reached as high as $5.5 million in Q1 2022 and fell as low as $1.8 million in Q1 2026.
• Historically, Operating Leases has averaged $2.9 million across 5 years, with a median of $2.8 million in 2024.
• Across the five-year window, Operating Leases slipped 1.01% in 2022 and tumbled 41.87% in 2023, its largest moves.
• Year by year, Operating Leases stood at $3.3 million in 2022, then declined by 12.39% to $2.9 million in 2023, then slipped by 15.87% to $2.4 million in 2024, then decreased by 21.14% to $1.9 million in 2025, then decreased by 7.19% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $1.8 million in Q1 2026, $1.9 million in Q4 2025, and $2.1 million in Q3 2025.